Janux Therapeutics
JANX
JANX
173 hedge funds and large institutions have $1.51B invested in Janux Therapeutics in 2025 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 80 increasing their positions, 54 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $1.81B → $1.51B (-$292M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
32% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 22
Holders
173
Holding in Top 10
5
Calls
$20.2M
Puts
$15.1M
Top Buyers
| 1 | +$46.6M | |
| 2 | +$14M | |
| 3 | +$13.8M | |
| 4 |
O
OrbiMed
New York
|
+$11.9M |
| 5 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
+$11.1M |
Top Sellers
| 1 | -$29.8M | |
| 2 | -$18M | |
| 3 | -$17.9M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$17.1M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$13.4M |